全文获取类型
收费全文 | 185169篇 |
免费 | 14127篇 |
国内免费 | 4679篇 |
专业分类
耳鼻咽喉 | 1115篇 |
儿科学 | 2749篇 |
妇产科学 | 1728篇 |
基础医学 | 12431篇 |
口腔科学 | 2430篇 |
临床医学 | 16396篇 |
内科学 | 18460篇 |
皮肤病学 | 1852篇 |
神经病学 | 12570篇 |
特种医学 | 3959篇 |
外国民族医学 | 8篇 |
外科学 | 12061篇 |
综合类 | 37614篇 |
一般理论 | 4篇 |
预防医学 | 17708篇 |
眼科学 | 1477篇 |
药学 | 23290篇 |
432篇 | |
中国医学 | 32484篇 |
肿瘤学 | 5207篇 |
出版年
2023年 | 2938篇 |
2022年 | 4976篇 |
2021年 | 7321篇 |
2020年 | 8398篇 |
2019年 | 11138篇 |
2018年 | 6135篇 |
2017年 | 6744篇 |
2016年 | 6185篇 |
2015年 | 6038篇 |
2014年 | 15017篇 |
2013年 | 13683篇 |
2012年 | 13868篇 |
2011年 | 13837篇 |
2010年 | 10902篇 |
2009年 | 8656篇 |
2008年 | 7918篇 |
2007年 | 7858篇 |
2006年 | 6532篇 |
2005年 | 5349篇 |
2004年 | 4291篇 |
2003年 | 3700篇 |
2002年 | 2995篇 |
2001年 | 2614篇 |
2000年 | 2217篇 |
1999年 | 1670篇 |
1998年 | 1375篇 |
1997年 | 1318篇 |
1996年 | 1059篇 |
1995年 | 1063篇 |
1994年 | 1007篇 |
1993年 | 796篇 |
1992年 | 741篇 |
1991年 | 721篇 |
1990年 | 580篇 |
1989年 | 520篇 |
1988年 | 514篇 |
1987年 | 476篇 |
1986年 | 440篇 |
1985年 | 1238篇 |
1984年 | 1636篇 |
1983年 | 1199篇 |
1982年 | 1228篇 |
1981年 | 1170篇 |
1980年 | 1056篇 |
1979年 | 968篇 |
1978年 | 840篇 |
1977年 | 591篇 |
1976年 | 670篇 |
1975年 | 528篇 |
1974年 | 497篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Osnat Bairey MD Alisa Taliansky MD Amir Glik MD Alexandra Amiel MD Shlomit Yust-Katz MD Ronit Gurion MD Miri Zektser MD Tzvika Porges MD Nadav Sarid MD Netanel A. Horowitz MD Tzahala Tzuk Shina MD Eyal Lebel MD Amos Cohen MD Karyn Revital Geiger MD Pia Raanani MD Ofir Wolach MD Tali Siegal MD 《Cancer》2023,129(24):3905-3914
2.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
3.
4.
5.
Considerable advances have been made in the research and development of oligonucleotide therapeutics (OTs) for treating central nervous system (CNS) diseases, such as psychiatric and neurodegenerative disorders, because of their promising mode of action. However, due to the tight barrier function and complex physiological structure of the CNS, the efficient delivery of OTs to target the brain has been a major challenge, and intensive efforts have been made to overcome this limitation. In this review, we summarize the representative methodologies and current knowledge of biodistribution, along with the pharmacokinetic/pharmacodynamic (PK/PD) relationship of OTs in the CNS, which are critical elements for the successful development of OTs for CNS diseases. First, quantitative bioanalysis methods and imaging-based approaches for the evaluation of OT biodistribution are summarized. Next, information available on the biodistribution profile, distribution pathways, quantitative PK/PD modeling, and simulation of OTs following intrathecal or intracerebroventricular administration are reviewed. Finally, the latest knowledge on the drug delivery systems to the brain via intranasal or systemic administration as noninvasive routes for improved patient quality of life is reviewed. The aim of this review is to enrich research on the successful development of OTs by clarifying OT distribution profiles and pathways to the target brain regions or cells, and by identifying points that need further investigation for a mechanistic approach to generate efficient OTs. 相似文献
6.
7.
《Enfermedades infecciosas y microbiología clínica》2022,40(10):568-571
IntroductionHere, we propose a novel modified Carba NP test for detecting KPC-producing Enterobacterales using imipenem/relebactam.Material and methodsThe test performance was evaluated in a random selection of 160 previously molecularly characterized clinical isolates carrying the 110 blaKPC, 1 blaGES, 12 blaVIM, 4 blaIMP, 3 blaNDM and 42 blaOXA-48-like genes. The proposed method relies on the detection of imipenem hydrolysis in an imipenem/relebactam antibiotic solution and subsequent visual interpretation by color change.ResultsAll class A producing Enterobacterales (111/111) were detected using imipenem/relebactam as no visual appreciation of color change was perceived due to a nule hydrolysis of imipenem in the antibiotic solution. Overall, the assay showed 100% sensitivity (111/111) and specificity (69/69) for detecting class A KPC-producing Enterobacterales.DiscussionThe biochemical assay provides very reliable results for detecting KPC-producing Enterobacterales, with a turnaround time of less than 1 hour, minimum handling and no specialized equipment required. 相似文献
8.
9.
《La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne》2022,43(2):89-97
Anticytoplasmic neutrophil antibodies (ANCA)-associated vasculitis (AAV) are rare systemic immune-mediated diseases characterized by small vessel necrotizing vasculitis and/or respiratory tract inflammation. Over the last 2 decades, anti-MPO vasculitis mouse model has enlightened the role of ANCA, neutrophils, complement activation, T helper cells (Th1, Th17) and microbial agents. In humans, CD4T cells have been extensively studied, while the dramatic efficacy of rituximab demonstrated the key role of B cells. Many areas of uncertainty remain, such as the driving force of GPA extra-vascular granulomatous inflammation and the relapse risk of anti-PR3 AAV pathogenesis. Animal models eventually led to identify complement activation as a promising therapeutic target. New investigation tools, which permit in depth immune profiling of human blood and tissues, may open a new era for the studying of AAV pathogenesis. 相似文献
10.